NCT07022444

Brief Summary

Cataract is a major cause of blindness due to eye diseases. Methods for evaluating the degree of lens opacification in cataracts are divided into subjective and objective methods. The commonly used subjective method is the Lens Opacification Classification System (LOCS Ⅲ), while the objective methods mainly include the Dysfunctional Lens Index (DLI) of the Ray Tracing aberration analysis system, the PNS score of the Pentacam anterior segment analysis system, etc. Subjective diagnosis may lead to certain misjudgments, which have affected clinical diagnosis and treatment. There is an urgent need to add objective diagnostic measures to assist clinical work. The Scanning Source Optical Coherence Tomography (SS - OCT) biometer - IOL Master 700 forms an OCT imaging of the eye based on the swept - source optical coherence tomography (OCT) biometric technology. It can visually show the longitudinal section of the entire lens, and the clear display of the patient's lens tomographic OCT image is obtained through image visualization measurement. The main purpose of this study is to analyze the lens images obtained by the IOLmaster 700. Based on the current mainstream algorithm models such as ResNet - 34 and XGBoost, develop a heterogeneous accelerated artificial intelligence algorithm according to our research needs to accurately calculate the degree of lens opacification. And write image analysis software by ourselves to automatically calculate the required indicators and output them. Establish a heterogeneous accelerated artificial intelligence - assisted lens opacification grading and prediction system, supporting software for biometer equipment, and a cataract lens image database. The software provides online service functions, and all researchers can use the image analysis function of the software after logging in, truly realizing the sharing of large instrument supporting software operations. Thereby improving the accuracy and efficiency of clinical diagnosis and treatment, the prognostic prediction level of patients after cataract surgery, guiding clinical diagnosis and treatment more accurately, and at the same time, it can be used as a tool for community screening.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 15, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

June 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

June 15, 2025

Status Verified

June 1, 2025

Enrollment Period

3 months

First QC Date

June 8, 2025

Last Update Submit

June 8, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Cataract Grade

    Achieved cataract images from IOL-MASTER 700 will be graded by several experienced doctors. And each image will be graded in three parts: cortical, nuclear and posterior subcapsular opacification.

    3 months

  • AI predicted cataract grade

    Achieved cataract images from IOL-MASTER 700 will be used to train, validate and test the AI algorithm. Predicted grade will be carried out and each image will be graded by AI in three parts: cortical, nuclear and posterior subcapsular opacification.

    3 months

  • AI model performance

    To evaluate the model performance, several indices are introduced: Sensitivity, Specificity, Accuracy, Precision, F1 score, receiver operating characteristic curve and area under the curve.

    3 months

Study Arms (1)

Cataract patients

Patients with cataract diagnosed in hospital from October 2019 to October 2024.

Device: IOL-MASTER 700

Interventions

patients who were diagnosed cataract would go through tests with IOL-MASTER 700 to achieve ocular biometry parameters.

Cataract patients

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients who are diagnosed cataract at first visit with no eye surgery history.

You may qualify if:

  • A. Age between 18 and 90 years B. Diagnosed with age-related and/or complicated cataract (diagnosed according to LOCS III classification) C. The patient has signed an informed consent form

You may not qualify if:

  • A. Exclude patients with corneal diseases, uveitis, vitreoretinal diseases, or refractive media opacities caused by conditions such as retinal detachment with silicone oil tamponade B. History of previous ophthalmic disease treatment or surgery C. Poor-quality or missing imaging data D. Pupil diameter \< 2.5 mm or loss of fixation during examination, resulting in inability to obtain sufficient lens data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Training physician

Study Record Dates

First Submitted

June 8, 2025

First Posted

June 15, 2025

Study Start

June 15, 2025

Primary Completion

August 31, 2025

Study Completion

December 31, 2025

Last Updated

June 15, 2025

Record last verified: 2025-06